Hepatitis B Tables and Figures

Index
PAGE
DESCRIPTION
Table 3.1 Number and rate of reported cases of acute hepatitis B, by state or jurisdiction and nationally ― United States, 2013–2017.
Table 3.2 Number and rate of reported cases of acute hepatitis B, by selected characteristics — United States 2013–2017.
Table 3.3 Number of newly reported cases of confirmed chronic hepatitis B and reporting status, by state or jurisdiction — United States, 2017.
Table 3.4 Number and rate of deaths with hepatitis B listed as a cause of death among US residents, by demographic characteristic and year – United States, 2013–2017.
Table 3.5 Number of newly reported cases of perinatal hepatitis B, by state or jurisdiction — United States, 2017.
Figure 3.1 Actual number of acute hepatitis B cases submitted to CDC by states and estimated* number of acute hepatitis B cases — United States, 2013–2017.
Figure 3.2 Rates of reported acute hepatitis B cases, by state compared to the 2017 overall rate of acute hepatitis B — United States, 2016 and 2017.
Figure 3.3 Rates of reported acute hepatitis B, by age group — United States, 2002–2017.
Figure 3.4 Rates of reported acute hepatitis B, by sex — United States, 2002–2017.
Figure 3.5 Rates of reported acute hepatitis B, by race/ethnicity — United States, 2002–2017.
Figure 3.6 Availability of information on risk behaviors/exposures associated with reported cases of acute hepatitis B — United States, 2017.
Figure 3.7 Reported cases of acute hepatitis B, by risk behavior/exposure — United States, 2017.

Table 3.1. Number and rate* of reported cases† of acute hepatitis B, by state or jurisdiction and nationally ― United States, 2013–2017.

Table 3.1.
State 2013
No.
2013
Rate*
2014
No.
2014
Rate*
2015
No.
2015
Rate*
2016
No.
2016
Rate*
2017
No.
2017
Rate*
Alabama 90 1.9 117 2.4 101 2.1 59 1.2 82 1.7
Alaska 1 0.1 3 0.4 3 0.4 6 0.8 9 1.2
Arizona 28 0.4 31 0.5 25 0.4 14 0.2 26 0.4
Arkansas 50 1.7 28 0.9 36 1.2 49 1.6 46 1.5
California 138 0.4 110 0.3 160 0.4 115 0.3 126 0.3
Colorado 24 0.5 29 0.5 28 0.5 28 0.5 32 0.6
Connecticut 8 0.2 9 0.3 6 0.2 7 0.2 10 0.3
Delaware 14 1.5 8 0.9 8 0.8 3 0.3 9 0.9
District of Columbia U U U U U U U U
Florida 323 1.7 313 1.6 432 2.1 558 2.7 588 2.8
Georgia 104 1.0 103 1.0 119 1.2 100 1.0 106 1.0
Hawaii 4 0.3 6 0.4 14 1.0
Idaho 13 0.8 6 0.4 8 0.5 6 0.4 6 0.3
Illinois 94 0.7 58 0.5 55 0.4 37 0.3 27 0.2
Indiana 101 1.5 126 1.9 133 2.0 146 2.2 170 2.5
Iowa 11 0.4 9 0.3 16 0.5 10 0.3 12 0.4
Kansas 11 0.4 11 0.4 19 0.7 21 0.7 24 0.8
Kentucky 214 4.9 164 3.7 162 3.7 222 5.0 236 5.3
Louisiana 82 1.8 87 1.9 87 1.9 48 1.0 73 1.6
Maine 11 0.8 12 0.9 9 0.7 53 4.0 77 5.8
Maryland 43 0.7 40 0.7 40 0.7 27 0.4 34 0.6
Massachusetts 71 1.1 30 0.4 25 0.4 31 0.5 51 0.7
Michigan 53 0.5 50 0.5 56 0.6 45 0.5 61 0.6
Minnesota 19 0.4 16 0.3 19 0.3 21 0.4 23 0.4
Mississippi 55 1.8 48 1.6 50 1.7 31 1.0 44 1.5
Missouri 61 1.0 31 0.5 35 0.6 40 0.7 31 0.5
Montana 4 0.4 4 0.4 1 0.1 3 0.3
Nebraska 9 0.5 8 0.4 3 0.2 8 0.4 10 0.5
Nevada 29 1.0 21 0.7 25 0.9 22 0.7 30 1.0
New Hampshire 2 0.2 4 0.3
New Jersey 65 0.7 77 0.9 85 0.9 59 0.7 57 0.6
New Mexico 3 0.1 2 0.1 2 0.1 1 0.0 1 0.0
New York 117 0.6 95 0.5 80 0.4 103 0.5 81 0.4
North Carolina 75 0.8 100 1.0 165 1.6 170 1.7 190 1.8
North Dakota 2 0.3 2 0.3
Ohio 225 1.9 171 1.5 409 3.5 299 2.6 285 2.4
Oklahoma 40 1.0 57 1.5 37 0.9 32 0.8 41 1.0
Oregon 32 0.8 32 0.8 24 0.6 20 0.5 23 0.6
Pennsylvania 43 0.3 68 0.5 61 0.5 43 0.3 69 0.5
Rhode Island U U U U U U U U U U
South Carolina 58 1.2 37 0.8 30 0.6 34 0.7 40 0.8
South Dakota 5 0.6 3 0.4 2 0.2 2 0.2 2 0.2
Tennessee 262 4.0 232 3.5 243 3.7 204 3.1 215 3.2
Texas 142 0.5 122 0.5 159 0.6 156 0.6 106 0.4
Utah 5 0.2 11 0.4 10 0.3 5 0.2 18 0.6
Vermont 2 0.3 4 0.6 3 0.5 2 0.3 1 0.2
Virginia 72 0.9 61 0.7 69 0.8 56 0.7 61 0.7
Washington 33 0.5 44 0.6 34 0.5 45 0.6 45 0.6
West Virginia 195 10.5 186 10.1 272 14.7 268 14.6 212 11.7
Wisconsin 9 0.2 11 0.2 5 0.1 9 0.2 14 0.2
Wyoming U U U U U U 2 0.3
Total 3,050 1.0 2,791 0.9 3,370 1.1 3,218 1.0 3,409 1.1

Source: CDC, National Notifiable Diseases Surveillance System.

* Rate per 100,000 population.

† For case definition, see https://wwwn.cdc.gov/nndss/conditions/hepatitis-b-acute/

—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.

N: Not reportable. The disease or condition was not reportable by law, statue, or regulation in the reporting jurisdiction.

U: Unavailable. The data are unavailable.

Table 3.2. Number and rate* of reported cases† of acute hepatitis B, by selected characteristics — United States 2013–2017.

Table 3.2.
2013
No.
2013
Rate*
2014
No.
2014
Rate*
2015
No.
2015
Rate*
2016
No.
2016
Rate*
2017
No.
2017
Rate*
Total§ 3,050 1.0 2,791 0.9 3,370 1.1 3,218 1.1 3,409 1.1
Age group
  0 – 19 years 25 0.0 14 0.0 19 0.0 18 0.0 16 0.0
  20 – 29 years 332 0.8 282 0.6 348 0.8 286 0.6 271 0.6
  30 – 39 years 980 2.4 888 2.2 1,094 2.6 1,000 2.4 998 2.3
  40 – 49 years 880 2.1 818 2.0 961 2.4 906 2.2 1,028 2.5
  50 – 59 years 496 1.1 504 1.2 615 1.4 655 1.5 700 1.6
  60+ years 272 0.4 272 0.4 312 0.5 342 0.5 395 0.6
Sex
  Male 1,873 1.2 1,778 1.1 2,080 1.3 1,957 1.2 2,095 1.3
  Female 1,163 0.7 1,001 0.6 1,280 0.8 1,252 0.8 1,301 0.8
Race/ethnicity
  American Indian/Alaskan Native 18 0.7 21 0.8 18 0.7 14 0.5 19 0.7
  Asian/Pacific Islander 58 0.3 53 0.3 67 0.4 56 0.3 64 0.3
  Black, Non-Hispanic 382 0.9 343 0.8 398 1.0 386 0.9 411 1.0
  White, Non-Hispanic 1,830 0.9 1,713 0.9 2,150 1.1 2,059 1.0 2,197 1.1
  Hispanic 205 0.4 158 0.3 175 0.3 194 0.3 196 0.3
HHS Region¶
  Region 1 94 0.7 59 0.4 43 0.3 93 0.7 139 1.0
  Region 2 182 0.6 172 0.6 165 0.6 162 0.6 138 0.5
  Region 3 367 1.2 363 1.2 450 1.5 397 1.3 385 1.3
  Region 4 1,181 1.9 1,114 1.8 1,302 2.0 1,378 2.1 1,501 2.3
  Region 5 501 1.0 432 0.8 677 1.3 557 1.1 580 1.1
  Region 6 317 0.8 296 0.7 321 0.8 286 0.7 267 0.6
  Region 7 92 0.7 59 0.4 73 0.5 79 0.6 77 0.5
  Region 8 38 0.4 43 0.4 46 0.4 38 0.3 57 0.5
  Region 9 199 0.4 168 0.3 224 0.4 151 0.3 182 0.4
  Region 10 79 0.6 85 0.6 69 0.5 77 0.6 83 0.6

Source: CDC, National Notifiable Diseases Surveillance System.

* Rate per 100,000 population.

† For the case definition, see https://wwwn.cdc.gov/nndss/conditions/hepatitis-b-acute/

§ Numbers reported in each category may not add up to the total number of reported cases in a year due to cases with missing data or, in the case of race/ethnicity, cases categorized as “Other”.

¶ Health and Human Services Regions were categorized according to the grouping of states and US territories assigned under each of the ten Department of Health and Human Services regional offices (https://www.hhs.gov/about/agencies/iea/regional-offices/index.htmlexternal icon). For the purposes of this report, regions with US territories (Region 2 and Region 9) contain data from states only.

Table 3.3. Number of newly reported cases* of confirmed chronic hepatitis B and reporting status, by state or jurisdiction — United States, 2017.

Table 3.3.
State/Jurisdiction No. chronic hepatitis B
case reports submitted†
Alabama N
Alaska 50
Arizona 192
Arkansas N
California
Colorado 129
Connecticut N
Delaware 118
District of Columbia U
Florida 2,117
Georgia 860
Hawaii U
Idaho 53
Illinois 593
Indiana 285
Iowa 53
Kansas 60
Kentucky N
Louisiana 184
Maine 60
Maryland 689
Massachusetts 406
Michigan 456
Minnesota 344
Mississippi N
Missouri 411
Montana 23
Nebraska 59
Nevada 26
New Hampshire U
New Jersey 244
New Mexico 39
New York 2,053
North Carolina 551
North Dakota 30
Ohio 733
Oklahoma 69
Oregon 122
Pennsylvania 870
Rhode Island
South Carolina 195
South Dakota 32
Tennessee N
Texas N
Utah 73
Vermont 44
Virginia 526
Washington 335
West Virginia 295
Wisconsin
Wyoming 12
Total 13,391

Source: CDC, National Notifiable Diseases Surveillance System.

* For case definition, see https://wwwn.cdc.gov/nndss/conditions/hepatitis-b-chronic/

† Reports may not reflect unique cases.

—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.

N: Not reportable. The disease or condition was not reportable by law, statue, or regulation in the reporting jurisdiction.

U: Unavailable. The data are unavailable.

Table 3.4. Number and rate* of deaths with hepatitis B listed as a cause of death† among US residents, by demographic characteristic and year – United States, 2013–2017.

Table 3.4.
Demographic characteristic 2013
No.
2013 Rate
(95% CI)
2014
No.
2014 Rate
(95% CI)
2015
No.
2015 Rate
(95% CI)
2016
No.
2016 Rate
(95% CI)
2017
No.
2017 Rate
(95% CI)
Age Group (years)
0–34 39 0.03
(0.02-0.04)
35 0.02
(0.02-0.03)
30 0.02
(0.01- 0.03)
39 0.03
(0.02-0.04)
29 0.02
(0.01-0.03)
35–44 146 0.36
(0.30-0.42)
126 0.31
(0.26-0.37)
118 0.29
(0.24-0.34)
116 0.29
(0.23-0.34)
106 0.26
(0.21-0.31)
45–54 388 0.89
(0.80-0.97)
384 0.88
(0.80-0.97)
330 0.76
(0.68-0.85)
324 0.76
(0.67-0.84)
323 0.76
(0.68-0.85)
55–64 701 1.78
(1.65-1.91)
682 1.70
(1.57-1.83)
610 1.49
(1.37-1.61)
576 1.39
(1.28-1.50)
548 1.30 (1.20-1.41)
65–74 342 1.36
(1.21-1.50)
356 1.35
(1.21-1.49)
382 1.39
(1.25-1.53)
383 1.34
(1.20-1.47)
417 1.40
(1.27-1.54)
75+ 250 1.28
(1.12-1.44)
254 1.28
(1.12-1.44)
236 1.17
(1.02-1.32)
252 1.22
(1.07-1.37)
303 1.43
(1.27-1.59)
Race/ethnicity
White, NH (non-Hispanic) 866 0.32
(0.30-0.34)
851 0.33
(0.30-0.35)
805 0.28
(0.26-0.30)
767 0.29
(0.27-0.31)
776 0.28
(0.26-0.30)
Black, NH 384 0.98
(0.88-1.08)
330 0.81
(0.72-0.89)
318 0.75
(0.67-0.84)
315 0.73
(0.65-0.81)
320 0.74
(0.66-0.83)
Hispanic 150 0.37
(0.31-0.43)
156 0.40
(0.33-0.46)
136 0.32
(0.27-0.38)
128 0.30
(0.25-0.36)
109 0.26
(0.21-0.32)
Asian/Pacific Islander 446 2.59
(2.34-2.84)
475 2.69
(2.44-2.93)
419 2.23
(2.01-2.45)
454 2.38
(2.16-2.60)
492 2.45
(2.23-2.67)
American
Indian/Alaskan Native
13 10 13 16 17
Sex
Male 1,373 0.79
(0.75-0.83)
1,301 0.74
(0.70-0.78)
1,270 0.70
(0.66-0.74)
1,231 0.67
(0.64-0.71)
1,275 0.70
(0.66-0.74)
Female 493 0.26
(0.23-0.28)
536 0.27
(0.24-0.29)
437 0.21
(0.19-0.23)
459 0.22
(0.20-0.24)
452 0.23
(0.20-0.25)
Overall 1,866 0.53
(0.50-0.55)
1,837 0.50
(0.47-0.52)
1,707 0.46
(0.44-0.49)
1,690 0.45
(0.43-0.48)
1,727 0.46
(0.44-0.49)

Source: CDC, National Center for Health Statistics, Multiple Cause of Death 1999–2017 on CDC WONDER Online Database. Data are from the 2013–2017 Multiple Cause of Death files and are based on information from all death certificates filed in the vital records offices of the fifty states and the District of Columbia through the Vital Statistics Cooperative Program. Deaths of nonresidents (e.g., nonresident aliens, nationals living abroad, residents of Puerto Rico, Guam, the Virgin Islands, and other territories of the US) and fetal deaths are excluded. Accessed at http://wonder.cdc.gov/mcd-icd10.html on August 23, 2019. CDC WONDER dataset documentation and technical methods can be accessed at https://wonder.cdc.gov/wonder/help/mcd.html#.

* Rates for race/ethnicity, sex, and the overall total are age-adjusted per 100,000 U.S. standard population in 2000 using the following age group distribution (in years): <1, 1–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84, and 85+. Missing data are not included. Rates where death counts were less than 20 were not displayed due to the instability associated with those rates. For age-adjusted death rates, the age-specific death rate is rounded to one decimal place before proceeding to the next step in the calculation of age-adjusted death rates for NCHS Multiple Cause of Death on CDC WONDER. This rounding step may affect the precision of rates calculated for small numbers of deaths.

† Cause of death is defined as one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B16, B17.0, B18.0, B18.1 (hepatitis B).

Note: Numbers are slightly lower than previously reported for 2013–2016 due to NCHS standards which restrict displayed data to US residents.

Table 3.5. Number of newly reported cases* of perinatal hepatitis B, by state or jurisdiction — United States, 2017.

Table 3.6.
State/Jurisdiction No. Perinatal hepatitis B
case reports submitted
Alabama 1
Arizona 1
California 5
Georgia 1
Hawaii 2
Indiana 1
Kentucky 1
Louisiana 1
Michigan 1
Mississippi 1
Nevada 1
New York 5
North Carolina 2
Ohio 3
Oregon 1
Pennsylvania 2
Texas 2
Total 31

Source: CDC, National Notifiable Diseases Surveillance System.

*For case-definition, see https://wwwn.cdc.gov/nndss/conditions/hepatitis-b-perinatal-virus-infection/

Figure 3.1. Actual number of acute hepatitis B cases submitted to CDC by states and estimated* number of acute hepatitis B cases — United States, 2013–2017.

Bar chart for years 2013 through 2017. Y axis has number of cases, ranging from 0 to 25,000

Source: CDC, National Notifiable Diseases Surveillance System.

* The number of estimated viral hepatitis cases was determined by multiplying the number of reported cases by a factor that adjusted for under-ascertainment and under-reporting (5). Corrected multipliers and confidence intervals developed by the CDC are shown in the Appendix A. In this visual representation, the sum of reported and estimated not reported total the estimated number of acute cases.

Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.2. Rates of reported acute hepatitis B cases, by state compared to the 2017 overall rate of acute hepatitis B — United States, 2016 and 2017.

Bar chart with states listed on the Y axis with rate per 100,000 along the x axis, ranging from 0 to 10.  Each state has a bar for 2016 and bar for 2017.

Source: CDC, National Notifiable Diseases Surveillance System.

Downloads of this slide: PDFpdf icon

Figure 3.3. Rates of reported acute hepatitis B, by age group — United States, 20022017.

Line chart with years 2002 through 2017 along the x axis and Reported cases per 100,000 population along the Y axis, ranging from 0 to 6.  A line for each of seven age ranges is plotted.

Source: CDC, National Notifiable Diseases Surveillance System.

Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.4. Rates of reported acute hepatitis B, by sex — United States, 2002–2017.

Line chart with years 2002 through 2017 along the x axis and Reported cases per 100,000 population along the Y axis, ranging from 0 to 4.  Lines for male and female are plotted.

Source: CDC, National Notifiable Diseases Surveillance System.

Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.5. Rates of reported acute hepatitis B, by race/ethnicity — United States, 2002–2017.

Line chart with years 2002 through 2017 along the x axis and Reported cases per 100,000 population along the Y axis, ranging from 0 to 6.  Lines for 5 different race/ethnicity groups are plotted.

Source: CDC, National Notifiable Diseases Surveillance System.

Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.6. Availability of information on risk behaviors/exposures* associated with reported cases of acute hepatitis B — United States, 2017.

Pie chart with three sections: Risk identified=29.7%, No risk identified=32.9%, and Risk data missing=37.4%.

Source: CDC, National Notifiable Diseases Surveillance System.

* Includes case reports indicating the presence of at least one of the following risks 6 weeks to 6 months prior to onset of symptomatic hepatitis B: 1) injection drug use; 2) sexual contact with suspected/confirmed hepatitis B patient; 3) being a man who has sex with men; 4) multiple sex partners concurrently; 5) household contact with suspected/confirmed hepatitis B patient; 6) occupational exposure to blood; 7) hemodialysis patient; 8) received a blood transfusion; 9) sustained a percutaneous injury; and 10) underwent surgery.

Downloads of this slide: PDFpdf icon    PowerPointppt icon

Figure 3.7. Reported cases of acute hepatitis B*, by risk behavior/exposure — United States, 2017.

Bar chart with risk behavior/exposure groups listed on the Y axis and Reported cases, ranging from 0 to 3,000, along the X axis.

Source: CDC, National Notifiable Diseases Surveillance System.
* A total of 3,409 case reports of hepatitis B were received in 2017.
† More than one risk behavior/exposure may be indicated on each case report.
§ No risk data reported.
¶ A total of 2,095 acute hepatitis B cases were reported among males in 2017.

Downloads of this slide: PDFpdf icon    PowerPointppt icon